These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29996478)

  • 1. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma.
    Lamar JM; Motilal Nehru V; Weinberg G
    Cancers (Basel); 2018 Jul; 10(7):. PubMed ID: 29996478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
    Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
    Elife; 2021 Apr; 10():. PubMed ID: 33913810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma.
    Seavey CN; Pobbati AV; Rubin BP
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740643
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Seavey CN; Pobbati AV; Hallett A; Ma S; Reynolds JP; Kanai R; Lamar JM; Rubin BP
    Genes Dev; 2021 Apr; 35(7-8):512-527. PubMed ID: 33766982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma.
    Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D
    Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of CDKN2A Cooperates with WWTR1(TAZ)-CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma.
    Seavey CN; Hallett A; Li S; Che K; Pobbati AV; Ma S; Burtscher A; Kanai R; Lamar JM; Rubin BP
    Clin Cancer Res; 2023 Jul; 29(13):2480-2493. PubMed ID: 36598859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
    Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
    Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
    Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
    Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncogenic fusion protein TAZ::CAMTA1 promotes genomic instability and senescence through hypertranscription.
    Neil E; Paredes R; Pooley O; Rubin B; Kouskoff V
    Commun Biol; 2023 Nov; 6(1):1174. PubMed ID: 37980390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
    Doyle LA; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms.
    Anderson WJ; Fletcher CDM; Hornick JL
    Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
    Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
    Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations.
    Yamaguchi H; Taouk GM
    Front Oncol; 2020; 10():928. PubMed ID: 32596154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Model Systems for Investigating Epithelioid Haemangioendothelioma.
    Neil E; Kouskoff V
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.
    Lee NH; Kim SJ; Hyun J
    Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma.
    Hayashi H; Uemura N; Zhao L; Matsumura K; Sato H; Shiraishi Y; Baba H
    Front Oncol; 2021; 11():700315. PubMed ID: 34395269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhu B; V M; Finch-Edmondson M; Lee Y; Wan Y; Sudol M; DasGupta R
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells.
    Lee Y; Finch-Edmondson M; Cognart H; Zhu B; Song H; Low BC; Sudol M
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.